Biocol Labs sits at the intersection of three interconnected challenges in the pharmaceutical and healthcare worlds: distrust, naturality and education.
Distrust. Traditional pharmaceutical models, built on over-the-counter chemical drugs to treat sick care, have left consumers confused and wary. More than 50% of Americans who take medication for an ailment wish an alternative existed. The industry has done enormous good for global health, but it also carries a history of putting profit before people: promoting addictive drugs as safe, and pricing life-saving treatments out of reach for many who need them.
Naturality. As the global wellness movement grows, consumers are paying closer attention to what they put in their bodies, and many are choosing natural medicine over pharmaceutical alternatives. Plants have been part of medical practice for thousands of years, while a growing number of modern prescriptions are being questioned for weak or undesirable outcomes. Scientists have challenged the widespread use of antidepressants after a major review found no clear evidence that low serotonin levels cause depression.
Education. The explosion of online (mis)information makes it hard to know what to trust about medical treatments and protocols. COVID-19 brought this into sharp focus, but the problem predates 2020. Studies have found that up to 87% of social media posts on topics like smoking, opioids and marijuana contain misinformation. Reliable, science-based information has never mattered more.
